all investments current investments previous investments


Medical Technology company developing a device to improve the care of type 2 diabetic patients.


Chrono is building a next generation transdermal drug delivery wearable that integrates biologically-timed drug delivery with personalised digital support. First application is nicotine replacement therapy for the smoking cessation market.


EndoStim has developed an implantable neuromodulation system for the treatment of severe gastro esophageal reflux disease (GERD).


Gynesonics designs and develops new and advanced technologies for improving women’s health. The company is focused on providing to women, and the physicians who care for them, an incision-free, uterus-preserving option to treat symptomatic uterine fibroids. The Sonata™ system combines intrauterine sonography with radio-frequency ablation to precisely locate and ablate uterine fibroids associated with heavy menstrual symptoms in a simple, same-day procedure. The system is cleared for sale in Europe (CE Mark) and the company is currently enrolling its US pivotal trial to evaluate safety and effectiveness. Sonata offers the potential to reduce the number of more invasive procedures, including hysterectomy, and to offer women greater choices in the treatment of this very common condition.




Sophia Genetics is a pioneer in Data-Driven Medicine, a crossover field that requires deep expertise in Next Generation Sequencing (NGS), combined with highly accurate and scalable predictive algorithms to diagnose genetic diseases.


Vertiflex develops and markets minimally invasive devices to treat disorders of the lumbar spine. The Superion device is a titanium interspinous process device (IPD) used to treat lumbar spinal stenosis, a common degenerative condition that affects millions of patients globally.
   


Medical technology company with a device to treat morbid obese patients. A gastric band restricts food intake, and is remotely controlled by the medical doctor. Company sold to Allergan (AGN) in February 2007.


Fully automated system for molecular biology diagnostics enabling easy DNA extraction and fast detection of bacteria.


Developing next generation treatment for brain aneurysms. Covidien acquired Nfocus Neuromedical in February 2013.


PneumRx is developing and marketing minimally invasive therapeutic devices to treat emphysema patients.


Symetis has developed a minimally invasive Transcatheter Aortic Valve Implantation (TAVI) system to treat patients suffering from aortic valve stenosis.


Develop, manufacture, and market dental implant systems. Sold participation in January 2006.
    


Medical Technology company developing a device to improve the care of type 2 diabetic patients.


Chrono is building a next generation transdermal drug delivery wearable that integrates biologically-timed drug delivery with personalised digital support. First application is nicotine replacement therapy for the smoking cessation market.


Medical technology company with a device to treat morbid obese patients. A gastric band restricts food intake, and is remotely controlled by the medical doctor. Company sold to Allergan (AGN) in February 2007.


EndoStim has developed an implantable neuromodulation system for the treatment of severe gastro esophageal reflux disease (GERD).


Fully automated system for molecular biology diagnostics enabling easy DNA extraction and fast detection of bacteria.


Gynesonics designs and develops new and advanced technologies for improving women’s health. The company is focused on providing to women, and the physicians who care for them, an incision-free, uterus-preserving option to treat symptomatic uterine fibroids. The Sonata™ system combines intrauterine sonography with radio-frequency ablation to precisely locate and ablate uterine fibroids associated with heavy menstrual symptoms in a simple, same-day procedure. The system is cleared for sale in Europe (CE Mark) and the company is currently enrolling its US pivotal trial to evaluate safety and effectiveness. Sonata offers the potential to reduce the number of more invasive procedures, including hysterectomy, and to offer women greater choices in the treatment of this very common condition.


Developing next generation treatment for brain aneurysms. Covidien acquired Nfocus Neuromedical in February 2013.


PneumRx is developing and marketing minimally invasive therapeutic devices to treat emphysema patients.




Sophia Genetics is a pioneer in Data-Driven Medicine, a crossover field that requires deep expertise in Next Generation Sequencing (NGS), combined with highly accurate and scalable predictive algorithms to diagnose genetic diseases.


Symetis has developed a minimally invasive Transcatheter Aortic Valve Implantation (TAVI) system to treat patients suffering from aortic valve stenosis.


Develop, manufacture, and market dental implant systems. Sold participation in January 2006.


Vertiflex develops and markets minimally invasive devices to treat disorders of the lumbar spine. The Superion device is a titanium interspinous process device (IPD) used to treat lumbar spinal stenosis, a common degenerative condition that affects millions of patients globally.
  
© Endeavour Vision SA 2006-2017 Terms & Conditions